Merck (MSD) announced that the US Food and Drug Administration (FDA) has approved Keytruda, Merck's anti-PD-1 therapy, in combination with gemcitabine and cisplatin for the treatment of patients with locally advanced unresectable or metastatic...
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical firm, has announced the signing of a development contract to produce a Ketamine formulation suited for intravenous administration in accordance with current FDA manufacturing rules...
Karyopharm Therapeutics recently announced that it and Bristol-Myers Squibb have partnered on a clinical trial to assess the efficacy of mezigdomide, a proprietary investigational cereblon E3 ligase modulator (CELMoD) agent, in combination with...
Aragen, a leading contract research development and manufacturing organization (CRDMO) for small molecules
Mumbai-based healthcare technology provider IKS Health announced on Tuesday that it has acquired AQuity Solutions
GSK plc announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III
Bengaluru-based biotechnology company, Eyestem Research, has recently formed a strategic partnership with Ikerian AG and RetinAI Inc.
InnoCare Pharma, a leading biopharmaceutical company focused on the treatment of cancer and autoimmune diseases,
Shanghai Henlius Biotech, Inc. reported exploratory new drug applications for the novel EGFR
According to Grant Thornton Bharat Pharma and Healthcare Dealtracker, deals in India's healthcare
, CDSCO.jpg)
